Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. | 10%+ Owner | Common Shares | 103M | $1.06B | $10.35 | Nov 10, 2022 | Direct |
Protalix BioTherapeutics, Inc. | 10%+ Owner | Common Stock | 3.64M | $5.13M | $1.41 | Jun 3, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd. | Nov 10, 2022 | 1 | $20M | 4 | Nov 14, 2022 | 10%+ Owner |
ROIV | Roivant Sciences Ltd. | Apr 22, 2022 | 2 | $155K | 4 | Apr 26, 2022 | 10%+ Owner |
ROIV | Roivant Sciences Ltd. | Oct 1, 2021 | 0 | $0 | 3 | Oct 1, 2021 | 10%+ Owner |
PLX | Protalix BioTherapeutics, Inc. | Jun 2, 2021 | 2 | -$2.09M | 4 | Jun 3, 2021 | 10%+ Owner |